Patients at Henry Ford Hospital now have a new cancer treatment available that offers an alternative cancer surgery, without the incision or hospital stay, treating patients in 15 minutes or less and returning them to their everyday lives.
The Edge™ Radiosurgery Suite is designed to perform advanced, non-invasive cancer procedures anywhere in the body – including the brain, spine, head and neck, adrenal gland, lung, liver and pancreas – with extreme precision and low toxicity.
It is the first unit in North America and only available at the Josephine Ford Cancer Institute at Henry Ford Hospital.
The Edge, created by Varian Medical Systems, uses new real-time tumor tracking technology and motion management capabilities, improving both safety and comfort for patients by protecting healthy tissue with sub-millimeter-accuracy. And its “cutting edge” beam offers the agility to treat tumors that may be difficult to reach surgically.
Treatments are typically outpatient and completed within the same week – with only one to five sessions.
Patients will begin treatment using the Edge this week at Henry Ford Hospital.
A pioneer in the use stereotactic radiation therapy, Henry Ford’s Department of Radiation Oncology has treated more than 4,000 patients using this specialized type of stereotactic radiation therapy.
And now, the Edge offers patients:
• Faster treatment: With a dose rate of up to 2,400 monitor units per minute, it offers rapid stereotactic treatments in only 10-20 minutes compared to other systems that can take well over an hour per session.
• Increased comfort: The six degrees (6D) of freedom treatment couch provides the accuracy, precision and flexibility needed to optimally position and adjust patients, allowing them to be comfortable and breathe freely during treatment.
• Real-time imaging: An advanced motion management package makes it possible to better compensate for tumor motion during treatment. The 2.5mm multi-leaf collimator provides a distinct cutting “edge” for radiosurgery treatments.
• Cost-effective medicine: The Edge can accurately treat the vast majority of what a proton beam center can do at a fraction of the cost of a proton unit.
“Henry Ford’s Department of Radiation Oncology has a long tradition of expertise with the most advanced radiation technologies, a heritage that will now continue with the addition the Edge,” says Benjamin Movsas, M.D., Chair of the Department of Radiation Oncology at Henry Ford.
“The Edge truly represents a novel platform in radiosurgery, offering a system that provides a fully-integrated solution for planning and administering radiosurgery treatments.”
“In radiosurgery, millimeters matter,” says neurosurgeon Steven N. Kalkanis, M.D., director of the Center for Cancer Surgery at Henry Ford. “The Edge radiosurgery suite is calibrated for sub-millimeter accuracy. That will help us rest assured that we are doing everything possible to protect normal tissues.”
Henry Ford Hospital was selected by Varian as the first site for the Edge in North American because it “represents and embodies clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them,” according to Chris Toth, vice president of marketing for Varian’s Oncology Systems business.
Henry Ford joins Champalimaud Foundation in Lisbon, Portugal, as the first two sites in the world with the Edge.
What is Stereotactic Radiation?
Stereotactic radiation is a procedure that precisely delivers intense radiation doses to tumor targets in one to five treatments. The goal of this non-invasive procedure is to destroy, or make inactive, the tumor while minimizing dose exposure to the surrounding healthy tissue.
The Latest on: Stereotactic Radiation
[google_news title=”” keyword=”Stereotactic Radiation” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Stereotactic Radiation
- Imaging technology can help aim radiation, make prostate cancer treatment saferon July 25, 2024 at 2:15 am
They reported their findings online Monday in the journal Cancer. The technique is called magnetic resonance-guided daily adaptive stereotactic body radiotherapy (MRg-A-SBRT). Reviewing studies ...
- Focused Radiation Is Safe, Effective for Metastatic Gynecologic Canceron July 22, 2024 at 9:39 am
Stereotactic ablative radiotherapy led to promising disease control in patients with metastatic gynecologic cancers, research showed.
- Navigating the Radiological Landscape: Insights into Radiotherapy and Nuclear Medicine Marketson July 22, 2024 at 1:44 am
Advancements in AI (Artificial Intelligence) technology is poised to revolutionize radiotherapy, enhancing patient outcomes, and streamlining clinical workflows. Meanwhile, the nuclear medicine ...
- ‘PGI OPDs see uptick in patients… advancements in cancer treatment have improved survival rates’on July 21, 2024 at 9:02 pm
Rakesh Kapoor, head, Department of Radiotherapy and Oncology, PGIMER, Chandigarh, tells Parul how early-stage cancer treatment with radiotherapy and technological advancements in the field has ...
- Robotic radiotherapy could ease treatment for eye diseaseon July 19, 2024 at 1:30 am
A single dose of stereotactic radiotherapy could reduce the number of eye injections needed to effectively control age-related macular degeneration ...
- Role of PET/CT Imaging in Stereotactic Body Radiotherapyon July 17, 2024 at 5:00 pm
Future Oncol. 2010;6(2):305-317. While the role of PET/CT in external beam radiotherapy has been evaluated, to date, no studies have evaluated its role in SBRT. A Phase I trial from our ...
- Radiation a Curative-Intent Option in NSCLC and Interstitial Lung Diseaseon July 17, 2024 at 5:00 pm
For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown. Stereotactic ablative radiotherapy (SABR) has ...
- Celiac plexus radiosurgery for pain management in advanced cancer: a multicentre, single-arm, phase 2 trialon July 16, 2024 at 5:19 pm
Celiac plexus radiosurgery could potentially be a non-invasive palliative option for patients with retroperitoneal pain syndrome. Further investigation by means of a randomised comparison with ...
- Conversations with oncology leaderson July 16, 2024 at 9:22 am
Bulman-Fleming: The field of oncology is ever-changing. New avenues include half-body radiation therapy for canine lymphoma, advancements in electrochemotherapy technology and immunotherapy. We have ...
- Immunotherapy Is Changing Cancer Treatment Foreveron July 15, 2024 at 2:01 am
One morning at the end of April 2023, Marcela Maus, a cancer researcher at Mass General in Boston, got a call from her colleague Bryan Choi. “He called me, and he’s like, ‘Oh my God, oh my God, oh my ...
via Bing News